Celldex Therapeutics, Inc. Liquidation Value
CLDX
Other
Cash & Equivalents
$28.87M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $28.87M
Total Obligations: -$53.33M
$-24.46M
Per share: $-0.37
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $28.87M
AR: $0
Total Obligations: -$53.33M
$-24.46M
Per share: $-0.37
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $28.87M
AR: $0
Inventory: $0
Total Obligations: -$53.33M
$-24.46M
Per share: $-0.37
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-24.46M | $-0.37 |
| Liquid Liquidation Value | $-24.46M | $-0.37 |
| Operating Liquidation Value | $-24.46M | $-0.37 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $28.87M |
| Accounts Receivable | $0 |
| Inventory | N/A |
| Current Liabilities | $50.99M |
| Long-term Debt | N/A |
| Op. Lease Liability | $2.34M |
| Finance Lease | N/A |
| Shares Outstanding | 66.5M |
Explore all 134 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $28.87M | $0 | N/A | $1.18M | $50.99M | N/A | $2.34M | N/A |
| 2025-09-30 | $36.04M | $0 | N/A | $4.27M | $46.47M | N/A | $2.62M | N/A |
| 2025-06-30 | $23.04M | $0 | N/A | $2.07M | $32.96M | N/A | $3.03M | N/A |
| 2025-03-31 | $17.14M | $0 | N/A | $3.41M | $32.02M | N/A | $3.43M | N/A |
| 2024-12-31 | $28.36M | $0 | N/A | $3.27M | $39.50M | N/A | $3.81M | N/A |
| 2024-09-30 | $36.40M | $0 | N/A | $1.11M | $32.09M | N/A | $3.09M | N/A |
| 2024-06-30 | $42.74M | $0 | N/A | $3.80M | $27.66M | N/A | $2.38M | N/A |
| 2024-03-31 | $115.08M | $0 | N/A | $3.23M | $26.29M | N/A | $2.11M | N/A |
▼ Community Notes